This announcement is a separate document:
AFT Pharmaceuticals Ltd: AFP welcomes US FDA approval for sale of Maxigesic IV
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.